JLABS @ NYC is now open! Click for more

Scroll down to exit

JLABS @ NYC is now open!

Mousewheel

This is a virtual reality demonstration. Click and drag the screen to look around

Loading

Get ready for a healthcare #innovation
revolution in the ‘city that never sleeps’

Check out
JLABS @ NYC
JLABS in innovation hotspots around the world

JLABS in innovation hotspots around the world

Because we know great ideas can come from everywhere. Whenever you feel inspired and are ready to move your breakthrough ideas in healthcare forward to reach patients and consumers, we have a community of state of the art JLABS waiting for you.

See all 11 locations

JLABS in the Press

"South San Francisco, Calif.-based Boost Biomes’ technology works to increase the productivity of beneficial microbes that impact how plants use water and soil nutrients."

Wall Street Journal

"If you’re driven by something that’s very mission-based, very values-based, then you’re willing to buck the system."

Entrepreneur Magazine

“Every week I meet companies on the edge of innovation and health care—new consumer products, pharmaceutical or biotech developments, as well as medical devices. I really do feel like I have the coolest job in San Diego.”

San Diego Magazine

"With the continued acceleration of novel science and health care technologies in areas like artificial intelligence, digital therapeutics and the human microbiome we have tremendous opportunity to search the haystack in new and exciting ways."

Scientific American

"Xconomy: What do you wish your 25-year-old self knew (or was told?) Melinda Richter: "You are good enough. You’re strong enough. You’re capable enough."

Xconomy

"Bringing the NY entrepreneurs and startups together with the investors is what we're all about."

Life Science Leader

"Silicon Valley isn't the only place to be a successful entrepreneur - you can be a hero in your home town - and that innovation resides as much outside big companies like J&J as it does inside; JLabs looks to catalyse innovation and accelerate it."

The Straits Times

Residents

Residents

Check out what some of our resident companies are working on, how they're tackling challenging problems in new and innovative ways.

Meet our residents

JLABS Resident Company Buzz

JLABS @ TMC

By: Intuitap Medical

Riding the Start-Up Roller Coaster: What It's Really Like to Be a Healthcare Entrepreneur

JLABS @ SSF

By: Ideaya Biosciences

IDEAYA Biosciences raised a $94M crossover Series B financing to develop next generation biomarker-enabled synthetic lethality therapies.

JLABS @ San Diego

By: Sirenas

Sirenas LLC. annouced today they have entered a muti-target research collaboration agreement with Bristol-Myers Squibb to deploy a drug discovery platform against undisclosed challenging therapeutic t...

JLABS @ Toronto

By: Nanovista Inc.

Nanovista Inc. closes $2.3 million seed round to advance its multimodal visualization agent towards clinical trials

JLABS @ MBC BioLabs

By: Symic Biomedical

Symic Bio Completes the MODIFY2 Phase 2 Trial of SB-061 for the Treatment of Knee Osteoarthritis

JLABS @ SSF

By: Imago Biosciences

Imago BioSciences Receives FDA Approval of IND Application for the Treatment of Myeloid Malignancies

JLABS @ Toronto

By: Advanced Proteome Therapeutics

Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, announced they are entering into a Collaboration and Option agreement...

JLABS @ TMC

By: ImmunoMet Therapeutics

JLABS TMC Company finds Growth in Shrinking Cells

JLABS @ Toronto

By: AVROBIO Inc.

With a potential cure for lysosomal storage disorders in hand, Avrobio raises $60M to back gene therapy pipeline

JLABS @ Toronto

By: AVROBIO Inc.

Avrobio, announced they have completed a $60M Series B round to back their gene therapy pipeline

JLABS @ Toronto

By: Biotagenics Inc.

Biotagenics Partners with University of Ottawa and CHEO on a $9.1 Million Project with Genome Canada to Develop Therapies for Inflammatory Bowel Disease

JLABS @ San Diego

By: Ensysce

Ensysce Biosciences has received Fast Track designation from the FDA for the development of abuse-resistant opioid drug PF614

Upcoming events

Up next

[Family Only] JLABS @ Toronto Summer Kick off

The Slip

Up next

Up and Out - Tips on navigating life science relocation (pt2)

Johnson & Johnson Innovation, JLABS

Up next

SDEE at JLABS: The Art of Effective Negotiation

JLABS

Up next

JOIN US to Learn about two new initiatives: YC for Biotech and Health Tech @ JLABS

Johnson & Johnson Innovation, JLABS

JLABS Conversation